MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its 2026 program selected just 65 companies from thousands of applications worldwide, representing the top 3%, with support from more than 500 industry experts. Tau Medical subsequently advanced to the Mid-Stage Grand Finals, recognizing the company’s achievements, commercial potential, and ability to transform patient care.
The competition took place on November 4, 2026, at the MedTech Strategist Innovation Summit in San Diego, where Tau Medical presented its technology and answered questions from a panel of judges representing Dexcom, LivaNova, Laerdal Million Lives Fund, and Stifel Bank. Tau Medical received a $25,000 finalist award.
Earlier, at The MedTech Conference 2026, held October 18–21 in Boston, Tau Medical participated in the MedTech Innovator Showcase: Innovative Cardiology Therapeutic Devices & Tools. Tau Medical joined representatives from Approxima, Spheric Bio, and Symphera for a session moderated by Sonal Patel, Vice President at Johnson & Johnson.
The showcase highlighted emerging cardiovascular technologies, providing Tau Medical an opportunity to introduce Pivot Extend® and its minimally invasive, anatomy-preserving approach to tricuspid valve repair to industry leaders, investors, and potential strategic partners.
Tau Medical extends its sincere appreciation to MedTech Innovator, Paul Grand, CEO, Nicole Black, Director, and the entire MTI team for their dedication, guidance, and support throughout the accelerator program. Their commitment to fostering medical technology innovation and connecting emerging companies with industry leaders, mentors, and strategic partners has been invaluable.
Together, these events marked an important milestone in Tau Medical’s growing international presence and its mission to expand treatment options for patients with tricuspid regurgitation.
